The admission of a patient to an intensive care unit (ICU) is associated with high levels of acute stress, anxiety, and depression among relatives, as well as extreme emotions such as fear, guilt, distress, and helplessness. In addition to these emotions, relatives also struggle to understand the information provided by the medical team-only half of the information is fully understood. These emotional and cognitive difficulties can become obstacles in decision-making processes and may have medium- and long-term consequences on their psychological well-being, particularly in terms of post-traumatic stress disorder (PTSD), anxiety, and depression. Three months after the patient is discharged from the ICU, one-third of relatives exhibit symptoms of PTSD. The aim of this research is to propose a variety of informational and educational tools to improve relatives' understanding of both the ICU context and the information provided, with the goal of reducing the risk of developing PTSD in the months following the patient's discharge or death.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
562
Universal welcome leaflet on patient admission
3 video capsules of 3 minutes each
3 cartoons
3 virtual reality programs
Including a video capsule, a cartoon, and a kit of two leaflets
Universal welcome leaflet on patient admission
Post-Traumatic Stress Disorder (PTSD)
Assessed with PCL-5 scale three months after the patient's discharge or death. The PCL-5 scale, Post-traumatic stress disorder CheckList version DSM-5 (PCL-5) \[PCL-5, 8/14/2013, Weathers, Litz, Keane, Palmieri, Marx, \& Schnurr - National Center for PTSD\] includes 20 items addressing PTSD symptoms according to DSM-5 criteria. Each item is rated from 0 ("not at all") to 4 ("extremely") for a total score between 0 and 80).
Time frame: At 3 months
Trial 1 : Measure the impact of each of the 3 sets of tools on the overall understanding of relatives in intensive care
Measure the impact of each of the 3 sets of informational and educational tools on the overall understanding of relatives in intensive care (diagnosis, prognosis, treatment) at the time of discharge from intensive care (questionnaire)
Time frame: Up to 6 months
Trial 1 : Measure the impact of each of the 3 sets of tools on the anxiety and depression symptoms of relatives
Measure the impact of each of the 3 sets of informational and educational tools on the anxiety and depression symptoms of relatives at the time of discharge from intensive care (HADS scale). HADS is a self-administered scale of 14 items which assessed levels of depression and anxiety, divided into 2 subscales of 7 items (Anxiety or HADS-A, Depression or HADS-D). Each item is scored on a scale of 0 to 3. A score is generated for each of the two sub-scales (sum of the 7 items, ranging from 0 to 21). Limit scores, for each of the scores, distinguish: non-cases or asymptomatic ones (score ≤ 7); probable or borderline cases (score 8-10); clearly or clinically symptomatic cases (score ≥ 11).
Time frame: Up to 6 months
Trial 1 & 2 : Sleep quality of relatives
Evaluated by ISI : Insomnia Severity Index It is a 7 questions scale. Each question is rated on a scale from 0 to 4, with 0 indicating no problems and 4 indicating very severe problems. The total score can range from 0 to 28, with higher scores indicating more severe insomnia.
Time frame: At inclusion
Trial 1 & 2 : Sleep quality of relatives
Evaluated by ISI : Insomnia Severity Index It is a 7 questions scale. Each question is rated on a scale from 0 to 4, with 0 indicating no problems and 4 indicating very severe problems. The total score can range from 0 to 28, with higher scores indicating more severe insomnia.
Time frame: At 3 months
Trial 1 & 2 : Sleep quality of relatives
Evaluated by ISI : Insomnia Severity Index It is a 7 questions scale. Each question is rated on a scale from 0 to 4, with 0 indicating no problems and 4 indicating very severe problems. The total score can range from 0 to 28, with higher scores indicating more severe insomnia.
Time frame: At 6 months
Trial 1 & 2 : Symptoms of post-traumatic dissociation
Evaluated by PDEQ : Post-traumatic Dissociation Questionnaire. Total score ranges from 0 to 48. The higher the score the more severe the dissociation symptoms are.
Time frame: At inclusion
Trial 1 & 2 : satisfaction of relatives regarding communication with the intensive care teams
Satisfaction assessed on a 8-step scale regarding communication with intensive care team
Time frame: At 3 months
Trial 1 & 2 Post-traumatic stress disorder
Trial 1 : Measure the impact of each of the 3 sets of informational and educational tools on the risk of developing post-traumatic stress disorder Trial 2 : Measure the impact of EOL of informational and educational tools on the risk of developing post-traumatic stress disorder Assessed with PCL-5 scale six months after the patient's discharge or death. The PCL-5 scale, Post-traumatic stress disorder CheckList version DSM-5 (PCL-5) \[PCL-5, 8/14/2013, Weathers, Litz, Keane, Palmieri, Marx, \& Schnurr - National Center for PTSD\] includes 20 items addressing PTSD symptoms according to DSM-5 criteria. Each item is rated from 0 ("not at all") to 4 ("extremely") for a total score between 0 and 80). 6 months after the patient's discharge or death
Time frame: At 6 months
Trial 1 & 2 : anxiety and depression symptoms of relatives
Trial 1 : Measure the impact of each of the 3 sets of informational and educational tools on the risk of developing anxiety and depression symptoms in relatives Trial 2 : Measure the impact of EOL informational and educational tools on the risk of developing anxiety and depression symptoms in relatives HADS is a self-administered scale of 14 items which assessed levels of depression and anxiety, divided into 2 subscales of 7 items (Anxiety or HADS-A, Depression or HADS-D). Each item is scored on a scale of 0 to 3. A score is generated for each of the two sub-scales (sum of the 7 items, ranging from 0 to 21). Limit scores, for each of the scores, distinguish: non-cases or asymptomatic ones (score ≤ 7); probable or borderline cases (score 8-10); clearly or clinically symptomatic cases (score ≥ 11). 3 months after the patient's discharge or death
Time frame: At 3 months
Trial 1 & 2 : anxiety and depression symptoms of relatives
Trial 1 : Measure the impact of each of the 3 sets of informational and educational tools on the risk of developing anxiety and depression symptoms in relatives Trial 2 : Measure the impact of EOL informational and educational tools on the risk of developing anxiety and depression symptoms in relatives HADS is a self-administered scale of 14 items which assessed levels of depression and anxiety, divided into 2 subscales of 7 items (Anxiety or HADS-A, Depression or HADS-D). Each item is scored on a scale of 0 to 3. A score is generated for each of the two sub-scales (sum of the 7 items, ranging from 0 to 21). Limit scores, for each of the scores, distinguish: non-cases or asymptomatic ones (score ≤ 7); probable or borderline cases (score 8-10); clearly or clinically symptomatic cases (score ≥ 11). 6 months after the patient's discharge or death
Time frame: At 6 months
Trial 1 & 2 : Past traumatic experiences
Trauma History Screen (THS) The THS typically asks individuals to respond to a series of yes/no questions about whether they've experienced specific types of trauma. They include : Physical abuse, Sexual abuse, Witnessing violence, Accidents or natural disasters, Military combat, Emotional abuse, Neglect. The score is the number of traumatic events.
Time frame: At 3 months
Trial 1 & 2 : Risk of developing prolonged grief 6 months after the patient's death
Trial 1 : Measure, in bereaved relatives, the impact of informational and educational tools on the risk of developing prolonged grief Trial 2 : Measure the impact of EOL informational and educational tools on the risk of developing prolonged grief Prolonged Grief Disorder Scale PG-13 The score ranges from 0 to 52. Total scores of 30 or above generally indicate that the individual may be experiencing Prolonged Grief Disorder (PGD) and should be considered for further evaluation. Lower scores suggest that the individual is not experiencing clinically significant prolonged grief symptom
Time frame: At 6 months
Trial 1 & 2 : Consumption of medical care and acts by relatives
Using MEDEC tool (medical care consumption and acts) It summarizes frequency and type of care
Time frame: At inclusion
Trial 1 & 2 : Consumption of medical care and acts by relatives
Using MEDEC tool (medical care consumption and acts) It summarizes frequency and type of care During the 6 months following the patient's discharge or death
Time frame: Up to 6 months
Trial 1&2 : Feasability of use of the tool
Trial 1 : Percentage of care provider who were able to hand over the 3 sets of informational and educational tools to the patient's relatives, as well as their satisfaction Trial 2 : Percentage of care provider who wereable to hand over the EOL informational and educational tools to the patient's relatives, as well as their satisfaction
Time frame: Up to 6 months
Trial 1 & 2 : Quality of tools assessed by families by a self-assessment questionnaire
self-assessment questionnaire with 14 items
Time frame: At 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.